80% of lung cancer cases are diagnosed in the latest stages of the disease.
EarlyCDT Lung is a simple blood test to identify people with a heightened risk of lung cancer for triage into CT scanning.
A finger prick or blood draw can be collected in the community, GP or hospital setting.
EarlyCDT Lung can detect lung cancer on average four years before standard of care  and has shown in a large NHS trial that it can reduce late stage lung cancer presentation by 36% .
Lung cancer kills 35,000 people every year in the UK accounting for 21% of all cancer deaths making it one of the leading causes of cancer death in the country.
I joined Oncimmune because I wanted to do something that would have an impact. The best chance we have of beating cancer is to detect it early. EarlyCDT Lung ticks all those boxes.
Huw Ricketts, Head of Global Alliances